SCHEMBL791145

SCHEMBL791145

COc1ccc(CNc2nc3ccc(-c4cncc(NC(=O)c5ccccc5)c4)cc3cc2-c2ccc(N3CCOCC3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.46
AURKB Q96GD4 1/20 0.45
RAB9A P51151 2/20 0.43
LRRK2 Q5S007 2/20 0.43
CTNNB1 P35222 1/20 0.43
TCF7L2 Q9NQB0 1/20 0.43
CLK1 P49759 1/20 0.43
DYRK1A Q13627 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 1/20 0.42
PIK3CA P42336 1/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
STAT6 P42226 1/20 0.41
CSF1R P07333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL789915 0.92 RAB9A (0.50) KDRAURKBRAB9ALRRK2CTNNB1
SCHEMBL790093 0.88 SMN1; SMN2 (0.48) KDRRAB9AKMT2AMEN1MAPT
SCHEMBL790621 0.88 KDR (0.46) KDRRAB9ACTNNB1TCF7L2CLK1
SCHEMBL790392 0.85 KDR (0.48) KDRAURKBRAB9ALRRK2MAPT
SCHEMBL790416 0.83 MRGPRX4 (0.50) KDRRAB9ALRRK2CLK1DYRK1A
SCHEMBL789889 0.83 RAB9A (0.48) KDRRAB9ACLK1DYRK1APIK3CA
SCHEMBL790553 0.81 ATR (0.49) RAB9AMAPTNPC1MAPK1TP53
SCHEMBL790646 0.81 KDR (0.47) KDRRAB9AKMT2AMEN1MAPT
SCHEMBL791199 0.79 RAB9A (0.50) KDRRAB9ACLK1DYRK1APIK3CA
SCHEMBL790788 0.72 NPC1 (0.54) RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed